Fate Therapeutics Receives $8,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35cf3b9d-cb34-4973-9953-0555e6611a86 - Date
5/18/2015 - Company Name
Fate Therapeutics - Mailing Address
3535 General Atomics Court San Diego, CA 92121 USA - Company Description
The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues. - Website
http://www.fatetherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$8,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
